On Monday 22 March 2021 Roche announced that dosing is being permanently discontinued in the GENERATION HD1 phase III trial evaluating the effect of tominersen, an ASO-based huntingtin lowering drug on the clinical course of HD. Dosing is also being paused on the open label extension study, GEN-EXTEND. This decision is the outcome of a […]
Catégorie : Uncategorized
Discontinuation of the GENERATION HD1 trial « Tominersen programme update – Community letter »
[…]
Amendments to the EHDN Constitution 2021
The comment period for the amendments to the EHDN Constitution is now open. […]
HDYO’s International Young Adult Virtual Congress
Supporting young people, all over the world, impacted by Huntington’s disease. […]
In Memory of Prof. Marina Frontali
In memory of Prof. Marina Frontali, who sadly passed away due to COVID-19. […]
EHDN Newsletter – 42nd edition
The EHDN newsletter (archive) aims to communicate the network’s activities and other developments of interest in the field of Huntington’s disease to the lay community, healthcare professionals and scientists. It appears three times a year (March 1, July 1, Nov 1). To receive EHDN news going forward, please subscribe to the EHDN news at the […]
ERN-RND webinars
ERN-RND provides free educational webinars on rare neurological and neuromuscular diseases – in collaboration with the European Reference Network for Rare Neuromuscular Diseases (EURO-NMD) and the European Academy of Neurology (EAN). The goal is to share knowledge on rare neurological, movement and neuromuscular disorders via a series of webinars presented by expert members of both […]
Dancing at the Vatican
Dancing at the Vatican is an inspirational documentary telling the story of a seemingly impossible journey made by families bound by the same devastating, genetically inherited disease, Huntington’s. Leaving the poorest corners of Latin America for the first time, they make it to Rome; not just to a Papal audience, but other, unimaginable, surprises. The […]
Journal of Huntington’s Disease – Volume 10, issue 1
The Journal of Huntington’s Disease is an international multidisciplinary journal to facilitate progress in understanding the genetics, molecular correlates, pathogenesis, pharmacology, diagnosis and treatment of Huntington’s disease and related disorders. […]
EHDN Newsletter – 41st edition
The EHDN newsletter (archive) aims to communicate the network’s activities and other developments of interest in the field of Huntington’s disease to the lay community, healthcare professionals and scientists. It appears three times a year (March 1, July 1, Nov 1). To receive EHDN news going forward, please subscribe to the EHDN news at the […]